Cheng-Lung Ku

10PUBLICATIONS
114CO-AUTHORS
Innate immunityAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)AllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 13, 2026
Highly neutralizing anti-IFN-ω autoantibodies underlie severe pediatric adenovirus infection.

|May 09, 2025
Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ.

Jhan-Jie Peng, Jing-Ya Ding, Yingxi Xu

|Apr 14, 2023
Metabolic challenges and interventions in CAR T cell therapy.

Jhan-Jie Peng, Limei Wang, Zhiyu Li

|Sep 16, 2022
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

Qian Zhang, Andrés Pizzorno, Lisa Miorin

|Aug 10, 2022
Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.

Shang-Yu Wang, Yu-Fang Lo, Han-Po Shih

|Jul 14, 2022
Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Han-Po Shih, Jing-Ya Ding, Junel Sotolongo Bellón

Pageof 2

Frequent Collaborators

4 joint publications

Jhan-Jie Peng

3 joint publications

Han-Po Shih

3 joint publications

Jing-Ya Ding

3 joint publications

Shang-Yu Wang